Card, T., Xu, J., Liang, H., & Bhayat, F. (2018). What Is the Risk of Progressive Multifocal Leukoencephalopathy in Patients With Ulcerative Colitis or Crohn’s Disease Treated With Vedolizumab? Inflamm Bowel Dis.
Citação norma ChicagoCard, Timothy, Jing Xu, Huifang Liang, and Fatima Bhayat. "What Is the Risk of Progressive Multifocal Leukoencephalopathy in Patients With Ulcerative Colitis or Crohn’s Disease Treated With Vedolizumab?" Inflamm Bowel Dis 2018.
MLA citiranjeCard, Timothy, Jing Xu, Huifang Liang, and Fatima Bhayat. "What Is the Risk of Progressive Multifocal Leukoencephalopathy in Patients With Ulcerative Colitis or Crohn’s Disease Treated With Vedolizumab?" Inflamm Bowel Dis 2018.
Opozorilo: Ti citati niso vedno 100% točni.